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bolic richness of L. majuscula and its relative amenability Pleasingly, the deduced gene sequence suggests
to culturing in the laboratory makes it a model organism plausible mechanisms by which the alkynyl, vinyl, and
for developing genetic techniques applicable to cyano- pyrrolinone features are formed, although the timing and
bacteria and other marine microbes. mechanism of the critical halogenation reactions remain
In this issue of Chemistry & Biology, Gerwick and uncertain. For example, the pathway contains a candi-
coworkers report the isolation of yet more bioactive date “-modifying gene cassette” for vinyl group forma-
metabolites from L. majuscula—the novel lipopeptides tion similar to that observed in other PKS pathways,
jamaicamides A–C, which exhibit cytotoxicity toward such as mupirocin [11], and an NRPS condensation do-
cancer cells as well as sodium channel-blocking activity main homolog that may be involved in pyrrolinone ring
[1]. The jamaicamides have several notable structural formation. Although the goal of expressing the entire jam
features, including a rare alkynyl bromide, an unusually cluster in a heterologous host remains distant, specific
located vinyl chloride, and a terminal pyrrolinone func- genes from the pathway could have more immediate
tionality; the genes responsible for these functionalities value in attempts to create further structural diversity
are therefore very attractive targets for inclusion in an among polyketides and peptide natural products
engineering toolbox. Using feeding studies with isotopi- through genetic engineering.
cally labeled precursors, the authors were able to estab-
lish conclusively that the jamaicamides are of mixed
Kira Weissmanpolyketide-polypeptide origin. These experiments also
Department of Biochemistrysuggested the involvement of a 3-hydroxy-3-methylglu-
University of Cambridgetaryl-CoA synthase (HMGCS) in forming the vinyl chlo-
80 Tennis Court Roadride function [11].
Cambridge CB2 1GABased on this information, Gerwick and his colleagues
United Kingdomwere able to design specific probes for the PKS genes
of the jamaicamide pathway using conserved KS se-
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The central role of microtubules in the process of segre-Bending at Microtubule Interfaces
gating duplicated chromosomes before cell division
makes them an important target for antimitotic drugs.
Microtubules that make up the mitotic spindle are in a
delicate state of balance between assembly and disas-
sembly. This is important because both the formation
of the spindle and the movement of chromosomes toMicrotubule-destabilizing drugs alter the interfaces
opposite spindle poles depend on carefully coordinatedbetween subunits so that they cannot assemble into
extension or shrinkage at both ends of the microtubulesstraight filaments [1]. Most target -tubulin, but piro-
in the spindle. The protein subunits, -tubulin hetero-netin binds to the supposedly inactive  subunit [2].
dimers, together with two bound molecules of guano-This unusual drug binds covalently to lysine but is
nevertheless specific for -tubulin. sine triphosphate (GTP), assemble head to tail in a polar
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Figure 1. Ribbon Diagram of the Crystal Structure of the Tubulin-Stathmin Complex Showing the Binding Sites for Various Microtubule
Depolymerizing Drugs
Tubulin GTPase domains are colored pink, the activation domains are blue, and the central helices (H7) are yellow; the C-terminal helices are
in gray. Stathmin, shown in green, induces curvature of this short segment of tubulin protofilament, and its N-terminal domain caps one end
[1]. GTP is sandwiched between - and -tubulin subunits of each heterodimer; that bound to each -tubulin has been hydrolyzed to GDP
through contact with helix H8 and loop T7 of another -tubulin subunit. The depolymerizing drugs colchicine (CH) and podophyllotoxin (POD)
bind to similar sites on -tubulin. Pironetin binds to a lysine (K352, shown as a ball and stick model) on -tubulin [2]. Vinblastine (VB), with
which pironetin competes, binds to the GTPase domain of -tubulin, probably to loop T5 or the loop between H6 and H7. (Figure prepared
with Molscript [13].)
fashion as linear protofilaments, and these protofila- monomers of the heterodimer and is never hydrolyzed
because -tubulin has lysine at the lower end of helixments combine to make up a microtubule. Their atomic
H8, in place of glutamic acid (as in -tubulin E254) orstructure is known from 3.5 A˚ resolution maps, the first
aspartic acid (as in FtsZ), amino acids that are requiredof which came from electron crystallography of zinc-
for hydrolysis [4].induced two-dimensional sheets, subsequently refined
Although tubulin protofilaments with bound GDP are[3]. Recent data, including important information about
curved [8, 9], after GTP hydrolysis contacts betweenconformational change, have been obtained by X-ray
neighboring subunits in a microtubule constrain the pro-crystallography [1]. Each monomer has two main globu-
tofilaments to remain associated in a straight form. Thelar domains, on each side of a central helix. The larger
resulting tension is proposed to store conformationaldomain, comprising the N-terminal half of the polypep-
energy that is released during depolymerisation. Thetide, contains a binding site for guanosine nucleotide
straight structure solved to near-atomic resolution byon its surface, and this region also contacts the smaller
Nogales and colleagues [3] corresponds to the “strained”globular domain of the next subunit in the protofilament
state. When a microtubule disassembles, its protofila-(Figure 1).
ments roll up to form rings. The curved state seen inGTP is in direct contact with loops T1 to T6 of the
cocrystals of tubulin and the tubulin-sequestering pro-GTPase domain, and, during assembly into protofila-
tein stathmin [1] shows12 bends between the tubulinments, loop T7 and helix H8, in the smaller domain of
subunits (see Figure 1). Each stathmin molecule inter-the next subunit, are brought close to the phosphates
acts alongside a pair of tubulin heterodimers, while itsof the nucleotide [4]. The idea that the smaller globular
amino-terminal domain caps one of the -tubulin sub-
domain (of tubulin or of FtsZ, the bacterial monomeric
units, preventing any further interactions. Changes
homolog of tubulin) acts as a GAP (GTP hydrolysis- within the subunit, compared with the straight confor-
activating protein) [4, 5] to the GTPase domain has been mation, include a relative rotation between the GTPase
confirmed experimentally by mutagenesis of FtsZ [6, 7]. and activation domains. Contacts between subunits are
Also, in work that is soon to be published (M. Oliva, S.C. preserved by local movements of helices H6, H7 and
Cordell, and J. Lo¨we, submitted), a new crystal structure H8, and loop T5.
of a mutant FtsZ is revealed whose subunits form a The bending at all interfaces between monomers, both
dimer by interchanging their smaller globular domains, between and within heterodimers, was first seen by elec-
showing that each domain can fold up independently. tron microscopy [8, 9]. Bending in both places is unex-
These researchers have suggested that the GTPase do- pected because there is still GTP bound in the intradimer
main and the “activation” domain were once separate interface, and it occurs even in the absence of destabiliz-
proteins that became fused. The protofilament thus con- ing agents such as stathmin or colchicine. These obser-
sists of alternating GTPase domains and activation do- vations suggest some sort of cooperation between
mains (Figure 1). After assembly and hydrolysis, the lo- tubulin monomers, involving a signal between the nucle-
cation of the nucleotide at the center of the interface otide binding site and the bottom of the activation do-
prevents its exchange from -tubulin until the subunit main. The central helix H7, which is able to slide like a
disassembles. GTP bound to -tubulin is nonexchange- piston [1], seems the most likely means of communicat-
ing between these two surfaces.able, being permanently trapped between the two
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A variety of drugs appear to inhibit microtubule as- that peptide and measuring the binding of pironetin to
the mutated proteins, expressed in an in vitro translationsembly by favoring the curved conformation of tubulin
and thus a distorted protofilament structure that cannot system. Only the removal of lysine 352 completely inhib-
ited pironetin interaction. The high specificity of the drugsupport microtubule polymerization [10]. They can affect
the amount of curvature: heterodimers in rings induced for -tubulin, among all of the lysine-containing proteins
of a cell, is predicted to be due to a precise matchby cryptophycin-1 have 13 bends between them and
32 bends within [8]. Although this drug binds only to between the whole molecule and its binding site, as
shown by computational modeling in the paper. Thisthe  subunit, it protects both - and -tubulin against
proteolysis by trypsin, suggesting specific conforma- property and the relatively small size of the molecule
make pironetin a very promising candidate for chemo-tional changes in both subunits. The new crystal struc-
ture [1] confirms earlier predictions that colchicine binds therapy.
to -tubulin near to the interface between monomers.
Its binding location necessarily requires a distortion Linda A. Amos
within the dimer structure that would inhibit its polymer- MRC Laboratory of Molecular Biology
ization into straight protofilaments. In contrast, vinblas- Hills Road
tine, which turns protofilaments into tightly wound heli- Cambridge CB2 2QH
ces, binds to -tubulin somewhere on residues 175–213 United Kingdom
[11]. This peptide includes regions that are involved in
Selected Readingcontacts between dimers (Figure 1).
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